QualityStocksNewsBreaks Archives - Page 853 of 1422

FridayOct 09, 2020 2:04 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Looks to Compelling Opportunity Through Pending Reverse-Merger

Net Element (NASDAQ: NETE) previously entered a definitive agreement to merge with Mullen Technologies, a Southern California-based electric vehicle (“EV”) company, in a move intended to maximize shareholder value. The pending reverse-merger will allow privately-held Mullen stakeholders to acquire a majority of the new stock and accelerate the process of taking the company public, giving potential investors an opportunity to purchase relatively undervalued shares within the rapidly growing sector. Investors continue to divert capital into the EV industry, pushing EV stock prices to unprecedented levels. “We feel, after considering an array of strategic alternatives, that the agreement with Mullen provides…

FridayOct 09, 2020 12:10 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Simply Wall St Article

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, was featured in a Simply Wall St article. The piece highlights PCSA Co-Founder Patrick Lin’s recent stock purchase at near current price. The article reads, “Potential Processa Pharmaceuticals Inc. (NASDAQ: PCSA) shareholders may wish to note that the Co-Founder, Patrick Lin, recently bought US$125k worth of stock, paying US$4.00 for each share. While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just…

FridayOct 09, 2020 11:07 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Begins Manufacturing of Lead Drug Candidate in Europe

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its European manufacturer, BSP Pharmaceuticals S.p.A. ("BSP"), has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (“GBM”). GBM is an aggressive form of brain cancer currently considered incurable. “Our preparations for filing an IND for Berubicin require continued execution in both our clinical and manufacturing initiatives,” CNS Pharmaceuticals CEO John Climaco said in the news release. “With the manufacturing of our…

FridayOct 09, 2020 10:29 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Expansion in the US

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before the U.S. election, where six states will vote on cannabis legalization initiatives and the potential power shift at the federal level could lead to more progressive policies for the industry. Among the highlights, Canopy Rivers announced the following: TerrAscend Corp. commenced sales from its newly expanded State Flower cultivation facility in San Francisco; High Beauty Inc. introduced canBE, a new line of natural, aloe-based products…

ThursdayOct 08, 2020 3:52 pm

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES) Engages Leading Platform AdvisoryCloud for Next-Level Results

The Movie Studios (OTC: MVES), an independent motion-picture production and distribution company, recently retained the services of AdvisoryCloud, a leading platform for advisors. In this move, the company is taking a proactive approach in accessing specialized services and identifying and adding highly experienced talent to its team, with the ability to select board appointees from over 12,000 advisors. AdvisoryCloud enables companies — ranging from start-ups to multinational corporations — to assemble advisory boards of more than 100 senior executives in a matter of weeks. In turn, companies can also leverage the platform to glean specialized insight through a series of…

ThursdayOct 08, 2020 3:26 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers Real-Time Access to Pharmaceuticals to Increase Competition, Reduce Costs

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, assists pharmacies in cutting costs in an era where the pricing of medication poses a major challenge that significantly inflates health-care spending. Trxade’s pharmaceutical trading platform is designed to reduce costs, assisting smaller pharmacies to compete through providing radical price transparency and increased market competition. A recent article discussing this reads, “The online marketplace hosted by the Trxade Group offers pharmacies a real opportunity to reduce purchase costs. Called the Trxade Exchange, the platform gives small pharmacies access to the wider pharmaceutical distribution network, allowing them to search for and…

ThursdayOct 08, 2020 3:21 pm

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Research Report

VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent research report by Aegis Capital Corp. The report reads, “VistaGen is developing multiple therapeutic candidates for the treatment of anxiety, depression, and other CNS indications. VistaGen's development pipeline includes PH94B, a neuroactive nasal spray targeting Social Anxiety Disorder (‘SAD’), among other conditions, PH10, an additional neuroactive nasal spray for indications including Major Depressive Disorder (‘MDD’), and AV-101 an oral drug for psychiatric and other CNS disorders. We believe Phase 2 data in PH94B…

ThursdayOct 08, 2020 3:06 pm

QualityStocksNewsBreaks – Sugarmade Inc.’s (SGMD) BudCars Featured on ‘Cannabis Talk 101’

Sugarmade’s (OTCQB: SGMD) BudCars Cannabis Delivery Service was spotlighted during a recent episode of “Cannabis Talk 101.” BudCars founder and CEO Clinton Walker joined the program to discuss the history, future and impressive potential of the budding business in which Sugarmade holds strategic investment. Among other highlights, Walker discussed the upcoming opening of LA BudCars and the company’s planned expansion around the state. “We are a Northern California premier cannabis delivery service,” he said during the program. “We procure some of the best flower, edibles, concentrate. We make sure that we deliver with great service and good quality. And we’ve…

ThursdayOct 08, 2020 1:35 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces Board Appointment of Seasoned Retail Veteran

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced the appointment of retail industry veteran Frank Lazaran to its board of directors, effective Oct. 8, 2020. Lazaran will serve on the company’s audit and compensation committees. Simultaneous to the appointment, Bruce Leitch has decided to step down from the company's board of directors to focus on other business endeavors. “On behalf of the board, we are delighted to welcome Frank Lazaran as a full-time member of The Alkaline Water Company's Board of Directors,” WTER Chairman of…

Site Search

Company Search

Category: QualityStocksNewsBreaks